Evaluation of the effect of colchicine in the treatment of patients with COVID-19

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191104045328N7

Enrollment

Registered

2021-07-17

Start date

2021-08-06

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus disease 2019. Coronavirus infection, unspecified

Interventions

Intervention 1: Intervention group: in addition to the standard treatment, patients receive one 500 microgram of colchicine tablets daily for 10 days. Intervention 2: Control group: patients receive a

Eligibility

Sex/Gender

All

Age

16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with COVID-19 infection 16 years and older Patients admitted to the infectious ward of COVID-19 hospitals in Arak

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Existence of liver and kidney disorders Age less than 16 years

Design outcomes

Primary

Measure	Time frame
Duration of hospitalization. Timepoint: After patient discharge. Method of measurement: Days of hospitalization.;Oxygen saturation. Timepoint: The first, third, fifth and seventh day of hospitalization. Method of measurement: Oximeter pulse.;Laboratory findings (complete blood cell count, liver function test, serum urea and creatinine, creatine phosphokinase, serum sodium and potassium levels, blood sugar, serum magnesium level, serum lactate dehydrogenase level, ferritin). Timepoint: The first and seventh day of hospitalization. Method of measurement: Taking a blood sample.	—

Measure

Time frame

Duration of hospitalization. Timepoint: After patient discharge. Method of measurement: Days of hospitalization.;Oxygen saturation. Timepoint: The first, third, fifth and seventh day of hospitalization. Method of measurement: Oximeter pulse.;Laboratory findings (complete blood cell count, liver function test, serum urea and creatinine, creatine phosphokinase, serum sodium and potassium levels, blood sugar, serum magnesium level, serum lactate dehydrogenase level, ferritin). Timepoint: The first and seventh day of hospitalization. Method of measurement: Taking a blood sample.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hosein Sarmadian

Arak University of Medical Sciences

hosseinsarmadian2015@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026